Can the future of antibiotic resistance be predicted?
How can Computational Biology change the foundations of infectious disease diagnostics?
Can antibiotic resistance be reversed?
Combining novel quantitative experimental techniques and clinical studies with mathematical modeling and advanced data analysis, we are studying microbial evolution with a specific focus on antibiotic resistance. We aim at understanding how bacterial pathogens evolve resistance to antibiotics within the human body during infection and how combinations of drugs can be used to slow down and perhaps even reverse this process.
Roy Kishony has recently joined the Technion from the Department of Systems Biology at Harvard Medical School.